PhageNova Bio Overview

  • Founded
  • 2012
Founded
  • Status
  • Private
  • Latest Deal Type
  • Early Stage VC
  • Investors
  • 4

PhageNova Bio General Information

Description

Developer of therapeutic products designed to offer treatment for cancer. The company's products maintain balance between maximizing therapeutic efficacy and minimizing toxicity by targeting tumor cells, enabling patients with advanced stage malignancies to recover faster.

Contact Information

Formerly Known As
AAVP Biosystems
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Drug Discovery
Other Industries
Pharmaceuticals
Primary Office
  • 89 Park Lane
  • West Harrison
  • Harrison, NY 10604
  • United States
+1 (617) 000-0000
Want detailed data on 2M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

PhageNova Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
4. Early Stage VC 27-Mar-2020 00000 Completed Generating Revenue
3. Equity Crowdfunding 00000 Completed Generating Revenue
2. Early Stage VC 05-Jun-2013 $600K Completed Generating Revenue
1. Seed Round $600K $600K Completed Startup
To view PhageNova Bio’s complete valuation and funding history, request access »

PhageNova Bio Executive Team (8)

Name Title Board Seat Contact Info
Jason Rifkin MD President & Chief Executive Officer
Lisa Velardo Chief Financial Officer
Renata Pasqualini Ph.D Co-Founder & Chief Scientific Officer
Steven Libutti MD Co-Founder & Director
Juri Gelovani Ph.D Co-Founder
You’re viewing 5 of 8 executive team members. Get the full list »

PhageNova Bio Board Members (2)

Name Representing Role Since
Keith Greenfield Self Board Member 000 0000
Timothy Rothwell JD Self Chairman 000 0000
To view PhageNova Bio’s complete board members history, request access »

PhageNova Bio Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
IBS Capital Hedge Fund Minority 000 0000 000000 0
Nathaniel Turner Angel (individual) Minority 000 0000 000000 0
Great Oaks Venture Capital Venture Capital Minority 000 0000 000000 0
Vivek Garipalli Angel (individual) Minority 000 0000 000000 0
To view PhageNova Bio’s complete investors history, request access »